U.S., Dec. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07304232) titled 'Post-transplantation Maintenance Therapy With Cidabenamide in Patients With Intermediate/High-risk AML' on Sept. 05.
Brief Summary: This study is a Phase II clinical trial designed to evaluate the efficacy and safety of Chidamide as maintenance therapy in high-risk acute myeloid leukemia (AML) patients following stem cell transplantation.
Trial Design: The trial is a single-arm, open-label study. The experimental group plans to enroll 67 patients, while the control group (observation only) also plans to enroll approximately 67 patients, with randomization. All patients must have received induction chemotherapy prior to enrollment a...